Skip to main content
Erschienen in: World Journal of Surgery 5/2006

01.05.2006

Sentinel Lymph Node Biopsy May Be Used to Support the Decision to Perform Modified Radical Neck Dissection in Differentiated Thyroid Carcinoma

verfasst von: Radan Dzodic

Erschienen in: World Journal of Surgery | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

The prognostic significance of lymph node metastases (LNM) in follicle cell-derived differentiated thyroid carcinoma (DTC) is still controversial. The management of cervical lymph nodes varies from “berry picking” to modified radical neck dissection (MRND). The incidence of LNM in papillary thyroid carcinoma varies from 27% to 80%. The importance of sentinel lymph node (SLN) biopsy for decisions about the surgical management of lymph nodes in DTC has been the subject of several previous studies.

Patients and Methods

In 40 patients with DTC methylene blue dye was applied peritumorally. Both SLN and non-SLN in the lower third of the jugulo-carotid chain were dissected prior to total thyroidectomy and routine dissection of the central neck compartment and examined by frozen-section and standard histology. MRND was performed in 9 cases of LNM in the lateral neck compartment.

Results

The SLN identification rate was 92.5%. Metastases in SLNs were revealed by frozen-section histology in 7 cases, leading to immediate MRND. The findings were confirmed on standard HE examination. In 2 false-negative cases SLN metastases were revealed on standard histology and MRND was performed 1 week later. The specificity of the method was 100%, sensitivity 77.7%, negative predictive value 94%, positive predictive value 100%, with overall accuracy of 95%.

Conclusion

Our results seem to imply that SLN biopsy in the jugulo-carotid chain using methylene blue dye mapping may be a feasible and valuable method for estimating lymph node status in the lateral neck compartment. It may be helpful in the detection of true-positive but nonpalpable lymph nodes, and in such cases may support the decision to perform MRND in patients with DTC.
Literatur
1.
Zurück zum Zitat Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 2000;6:469–476PubMed Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 2000;6:469–476PubMed
2.
Zurück zum Zitat Cady B. Presidential address: beyond risk groups—a new look at differentiated thyroid cancer. Surgery 1998;124:947–957PubMed Cady B. Presidential address: beyond risk groups—a new look at differentiated thyroid cancer. Surgery 1998;124:947–957PubMed
3.
Zurück zum Zitat Noguchi S, Yamashita H, et al. Changing trend of presentation of papillary carcinoma of the thyroid in the last 5 decades: experience in one institution. Int J Cancer 2002;13:216 Noguchi S, Yamashita H, et al. Changing trend of presentation of papillary carcinoma of the thyroid in the last 5 decades: experience in one institution. Int J Cancer 2002;13:216
4.
Zurück zum Zitat Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control 2000;7:240–245PubMed Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control 2000;7:240–245PubMed
5.
Zurück zum Zitat McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991;162:353–356PubMedCrossRef McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991;162:353–356PubMedCrossRef
6.
Zurück zum Zitat Akslen LA, Haldorsen T, Thoresen SO, et al. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res 1991;51:1234–1241PubMed Akslen LA, Haldorsen T, Thoresen SO, et al. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res 1991;51:1234–1241PubMed
7.
Zurück zum Zitat Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg 1988;12:825–829PubMedCrossRef Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg 1988;12:825–829PubMedCrossRef
8.
Zurück zum Zitat Attie JN. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer 1988;24:315–324CrossRef Attie JN. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer 1988;24:315–324CrossRef
9.
Zurück zum Zitat Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1999;114:1050–1058 Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1999;114:1050–1058
10.
Zurück zum Zitat Noguchi S, Murakami S, Yamashita H, et al. Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 1998;133:276–280PubMedCrossRef Noguchi S, Murakami S, Yamashita H, et al. Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 1998;133:276–280PubMedCrossRef
11.
Zurück zum Zitat Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804PubMed Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804PubMed
12.
Zurück zum Zitat Lacour J, L’Heritier M, Petit JY, et al. Surgical treatment of differentiated thyroid cancer at the Institut Gustave-Roussy. Ann Radiol (Paris) 1977;20:767–770 Lacour J, L’Heritier M, Petit JY, et al. Surgical treatment of differentiated thyroid cancer at the Institut Gustave-Roussy. Ann Radiol (Paris) 1977;20:767–770
13.
Zurück zum Zitat Scheumenn GFW, Gimm O, Wegner G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–567CrossRef Scheumenn GFW, Gimm O, Wegner G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–567CrossRef
14.
Zurück zum Zitat Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–466PubMed Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–466PubMed
15.
Zurück zum Zitat Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–399PubMed Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–399PubMed
16.
Zurück zum Zitat Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401PubMed Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401PubMed
17.
Zurück zum Zitat Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radio localisation of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993;2:335–340PubMedCrossRef Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radio localisation of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993;2:335–340PubMedCrossRef
18.
Zurück zum Zitat Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288–292PubMedCrossRef Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288–292PubMedCrossRef
19.
Zurück zum Zitat Fukui Y, Yamakawa T, Taniki T, et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001;92:2868–2874PubMedCrossRef Fukui Y, Yamakawa T, Taniki T, et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001;92:2868–2874PubMedCrossRef
20.
Zurück zum Zitat Arch-Ferrer J, Velazquez D, Fajardo R, et al. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 2000;130:907–913CrossRef Arch-Ferrer J, Velazquez D, Fajardo R, et al. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 2000;130:907–913CrossRef
21.
Zurück zum Zitat Catarci M, Zaraca F, Angeloni R, et al. Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid carcinoma. A pilot study. J Surg Oncol 2001;77:21–24PubMedCrossRef Catarci M, Zaraca F, Angeloni R, et al. Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid carcinoma. A pilot study. J Surg Oncol 2001;77:21–24PubMedCrossRef
22.
Zurück zum Zitat Takami H, Sasaki K, Ikeda Y, et al. Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J Surg 2003;26:145–148PubMedCrossRef Takami H, Sasaki K, Ikeda Y, et al. Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J Surg 2003;26:145–148PubMedCrossRef
23.
Zurück zum Zitat Tsugawa K, Ohnishi I, Nakamura M, et al. Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland. Biomed Pharmacother 2002;56(Suppl 1):100–103CrossRef Tsugawa K, Ohnishi I, Nakamura M, et al. Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland. Biomed Pharmacother 2002;56(Suppl 1):100–103CrossRef
24.
Zurück zum Zitat Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000;24:1396–1401PubMedCrossRef Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000;24:1396–1401PubMedCrossRef
25.
Zurück zum Zitat Mirallie E, Visset J, Sagan C, et al. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999;23(9):970–973PubMedCrossRef Mirallie E, Visset J, Sagan C, et al. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999;23(9):970–973PubMedCrossRef
26.
Zurück zum Zitat Noguchi M, Kumaki T, Taniya T, et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 1990;125:804–806PubMed Noguchi M, Kumaki T, Taniya T, et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 1990;125:804–806PubMed
27.
Zurück zum Zitat Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 1987;67:251–261PubMed Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 1987;67:251–261PubMed
28.
Zurück zum Zitat Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194–1198; discussion 1199PubMedCrossRef Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194–1198; discussion 1199PubMedCrossRef
29.
Zurück zum Zitat Wiseman S, Hicks W, Chu Q, et al. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 2002;11:137–142PubMedCrossRef Wiseman S, Hicks W, Chu Q, et al. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 2002;11:137–142PubMedCrossRef
30.
Zurück zum Zitat Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 2003;10:242–247PubMedCrossRef Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 2003;10:242–247PubMedCrossRef
31.
Zurück zum Zitat Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, Domino EF. Allergic reactions to isosulfan blue during sentinel node biopsy—a common event. Surgery 2001;130:439–442PubMedCrossRef Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, Domino EF. Allergic reactions to isosulfan blue during sentinel node biopsy—a common event. Surgery 2001;130:439–442PubMedCrossRef
Metadaten
Titel
Sentinel Lymph Node Biopsy May Be Used to Support the Decision to Perform Modified Radical Neck Dissection in Differentiated Thyroid Carcinoma
verfasst von
Radan Dzodic
Publikationsdatum
01.05.2006
Erschienen in
World Journal of Surgery / Ausgabe 5/2006
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0298-0

Weitere Artikel der Ausgabe 5/2006

World Journal of Surgery 5/2006 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.